by In2Pharma | May 14, 2019 | News
The Netherlands On 30 April 2019, the concept text for the Healthcare Transparency Register law was presented for consultation. With this concept law, the obligation for suppliers of medicines and medical devices to report financial relationships with healthcare...
by In2Pharma | Oct 19, 2018 | News
Belgium The main reason for the update of the Mdeon Code of Ethics is to align it with the Sunshine Act. Simultaneously, the Practical Guidelines of the code have been adapted as well. The two major changes are: Adaptation of the chapter on the transparency obligation...
by In2Pharma | Aug 31, 2017 | News
On 22 August 2017, the Royal Decree of 31 July 2017 was published in the Belgian Official Journal. This Royal Decree confirms the recognition of the non-profit-making association Mdeon to perform the transparency tasks that were entrusted to the FAMHP. Mdeon is now...
by In2Pharma | Jun 23, 2017 | News
Hot news: The Royal Decree (RD) that implements the Sunshine Act is published today, June 23rd 2017! We summarize the most important changes compared to the current practice on betransparent.be, which was solely based on the Deontological Codes of the industry...
by In2Pharma | Jun 20, 2017 | News
CGR In the Netherlands, 58.2 million euros have been reported to the Healthcare Transparency Register for 2016 which is a 13% increase in comparison with last year. For the fifth year in a row, transparency between pharmaceutical industry, healthcare professionals,...
